Stemedica Cell Technologies, Inc. products
Stemedica - Allogeneic Progenitor Cell
There are two types of cells currently used for investigating progenitor cell therapies for degenerative diseases: autologous and allogeneic. Autologous progenitor cells are derived from the patient being treated. They are retrieved surgically, expanded, and transplanted back into the same patient. Allogeneic progenitor cells are derived from healthy volunteers or organ donations. These cells are expanded and stored for future use in multiple medical conditions.
Stemedica - BioSmart Technology
Stemedica’s manufacturing technology is not Stemedica’s only advantage. Our cells undergo a battery of tests, monitoring and analysis to ensure the highest-quality cells that will operate predictably under clinical, pre-clinical, or research conditions.
Stemedica - Ischemia-Tolerant Mesenchymal Stem Cells
itMSCs (ischemia-tolerant mesenchymal stem cells) are “trophic” cells that circulate throughout the body and release proteins and growth factors into the damaged tissue, rescuing damaged cells from death and creating the right conditions for the newly mobilized cells to proliferate and repair. Stemedica’s itMSCs are extracted from donated bone marrow and then expanded using our proprietary technology.